The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
Xaira Therapeutics today announced the appointment of Ian McCaffery, Ph.D., as Senior Vice President, Translational Science and Early Clinical Development, and the promotions of Ci Chu, Ph.D., to ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...
ZME Science on MSN
Anthropic wants to make its own drugs with help from Claude
Anthropic wants to prove its chatbot can do more than write code or summarize documents. It wants Claude to help invent new ...
When life sciences startups think about patent strategy, the natural instinct is to focus on the core science — the novel compound, the ...
Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced successful results ...
The Hearty Soul on MSN
A drug that lets you grow new teeth is now in human trials
A drug targeting the USAG-1 protein entered human trials in Japan in 2024. Researchers aim to make third tooth regrowth ...
Discover how automation, AI, and organoid technologies are improving drug discovery through scalable workflows.
A joint research team has developed an automated design technology that enables the creation of DNA origami structures that ...
Lipid-based nanocarriers, particularly liposomes, have played a central role in the development of modern drug delivery ...
Researchers say newly identified cholesterol control pathway is completely separate from anything targeted by existing drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results